Oppenheimer Holdings
OPY
118.22
-2.36
-1.96%
Oppenheimer Holdings
US · OPY
#3079 by market cap
Listed 1970
118.22
-2.36
-1.96%
Live - 5344 symbols - heartbeat 228s ago
· 2026-10-08 04:01
Pre-market
118.22
0.00%
After-hours
118.22
0.00%
- Market cap
- 1.27B
- P/E (TTM)i
- 13.12
- P/Bi
- 1.29
- EPSi
- 13.04
- Div yieldi
- 0.63%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on OPY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.27, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.35% YoY
Margins
- Gross margin
- 36.25%
- Operating margin
- 25.90%
- Net margin
- 9.06%
Key ratios & quality
- PEG ratioi
- 0.20
- Altman Z-Scorei
- 2.27
PEG uses trailing P/E against the 3-year net income growth rate (66.16%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 958.15M | 1.03B | 1.20B | 1.39B | 1.11B | 1.25B | 1.43B | 1.64B |
| Gross profit | 327.98M | 353.70M | 404.69M | 484.89M | 344.55M | 441.50M | 468.04M | 593.72M |
| Selling & admin expenses | 135.65M | 143.79M | 144.48M | 140.59M | 145.37M | 157.32M | 163.21M | 169.46M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 192.33M | 209.92M | 260.21M | 344.30M | 199.18M | 284.18M | 304.83M | 424.26M |
| Pretax profit | 44.87M | 74.91M | 169.00M | 224.64M | 45.55M | 46.77M | 105.76M | 211.19M |
| Tax | 15.98M | 21.96M | 46.01M | 65.68M | 13.44M | 16.50M | 34.51M | 63.23M |
| Net profit | 28.89M | 52.95M | 122.99M | 158.96M | 32.11M | 30.27M | 71.25M | 147.96M |
| Basic EPS | 2 | 4 | 10 | 13 | 3 | 3 | 7 | 14 |
| Diluted EPS | 2.05 | 3.82 | 9.30 | 11.70 | 2.57 | 2.59 | 6.37 | 13.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 367.83M | 373.18M | 424.44M | 472.63M | 445.10M | 454.88M |
| Gross profit | 132.98M | 127.06M | 127.37M | 206.31M | 142.73M | 139.77M |
| Selling & admin expenses | 42.19M | 41.78M | 41.91M | 43.58M | 42.34M | 43.34M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 90.79M | 85.28M | 85.46M | 162.73M | 100.39M | 96.42M |
| Pretax profit | 41.38M | 32.21M | 31.64M | 105.97M | -27.00M | 39.45M |
| Tax | 10.72M | 10.54M | 9.92M | 32.05M | -6.43M | 12.09M |
| Net profit | 30.66M | 21.67M | 21.71M | 73.92M | -20.57M | 27.35M |
| Basic EPS | 3 | 2 | 2 | 7 | -2 | 3 |
| Diluted EPS | 2.72 | 1.91 | 1.90 | 6.51 | -1.93 | 2.38 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 982.55M | 1.14B | 1.48B | 2.12B | 1.86B | 2.21B | 2.73B | 3.06B |
| Cash & ST investments | 90.68M | 79.55M | 35.42M | 213.76M | 112.43M | 28.84M | 33.15M | 38.41M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 2.24B | 2.46B | 2.71B | 3.04B | 2.71B | 2.87B | 3.38B | 3.72B |
| Total current liabilities | 582.99M | 666.09M | 567.74M | 724.98M | 791.97M | 529.00M | 445.88M | 510.60M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 231.04M | 409.55M | 470.35M | 448.77M | 450.66M | 410.29M | 514.27M | 473.54M |
| Total liabilities | 1,694,992,000.00 | 1,872,033,000.00 | 2,028,235,000.00 | 2,090,220,000.00 | 1,893,971,000.00 | 2,085,577,000.00 | 2,532,331,000.00 | 2,725,386,000.00 |
| Total equity | 545.32M | 592.72M | 685.67M | 953.03M | 820.42M | 789.24M | 850.40M | 997.03M |
| Retained earnings | 449.99M | 497.00M | 601.41M | 740.93M | 764.18M | 756.47M | 819.96M | 947.41M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.80B | 2.95B | 3.11B | 3.06B | 3.16B | 3.35B |
| Cash & ST investments | 36.70M | 37.62M | 38.29M | 38.41M | 34.60M | 38.45M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.57B | 3.69B | 3.82B | 3.72B | 3.82B | 4.23B |
| Total current liabilities | 437.81M | 562.49M | 596.47M | 510.60M | 607.53M | 731.58M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 720.39M | 759.69M | 563.66M | 473.54M | 619.99M | 750.48M |
| Total liabilities | 2,699,916,000.00 | 2,790,481,000.00 | 2,897,874,000.00 | 2,725,386,000.00 | 2,849,637,000.00 | 3,234,071,000.00 |
| Total equity | 872.27M | 896.86M | 920.27M | 997.03M | 965.64M | 996.66M |
| Retained earnings | 848.72M | 867.92M | 887.74M | 947.41M | 924.91M | 950.12M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 168.57M | 79.14M | -54.06M | 227.79M | 64.49M | -18.81M | -108.17M | 188.75M |
| Depreciation & amortization | 6.87M | 32.82M | 33.29M | 34.12M | 34.41M | 37.21M | 37.29M | 37.74M |
| Free cash flow | 159.50M | 69.12M | -58.59M | 219.52M | 48.18M | -35.87M | -113.32M | 183.56M |
| Dividends paid | -5.83M | -5.94M | -18.58M | -19.44M | -7.04M | -6.45M | -6.85M | -7.58M |
| Stock buybacks / issuance | -5.82M | -8.32M | -14.99M | 118.82M | -60.51M | -35.05M | -9.54M | -2.98M |
| Ending cash balance | 90.68M | 79.55M | 35.42M | 341.52M | 137.97M | 28.84M | 33.15M | 38.41M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -91.74M | 40.07M | 63.42M | 177.00M | -189.98M | -55.03M |
| Depreciation & amortization | 9.28M | 9.48M | 9.47M | 9.51M | 9.39M | 9.62M |
| Free cash flow | -93.42M | 38.94M | 62.22M | 175.82M | -189.98M | -57.06M |
| Dividends paid | -1.90M | -1.89M | -1.89M | -1.89M | -12.41M | -2.14M |
| Stock buybacks / issuance | -90.00K | -581.00K | 0 | -2.31M | 0 | 0 |
| Ending cash balance | 36.70M | 37.62M | 38.29M | 38.41M | 34.60M | 38.45M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.41 | 9.31 | 19.24 | 21.07 | 4.00 | 3.81 | 8.73 | 16.18 |
| ROA %i | 1.24 | 2.25 | 4.75 | 5.52 | 1.12 | 1.08 | 2.29 | 4.18 |
| ROIC %i | 7.20 | 9.79 | 11.62 | 11.80 | 3.40 | 5.31 | 8.96 | 13.27 |
| 5-year avg ROE %i | 2.33 | 3.85 | 7.63 | 11.89 | 11.80 | 11.49 | 11.37 | 10.76 |
| EBIT margin %i | 9.52 | 11.67 | 15.41 | 16.82 | 6.25 | 9.24 | 13.53 | 18.18 |
| FCF / sales %i | 16.65 | 6.69 | -- | 15.75 | 4.34 | -- | -- | 11.21 |
| Current ratioi | 1.69 | 1.71 | 2.61 | 2.92 | 2.35 | 4.18 | 6.12 | 5.99 |
| Quick ratioi | 1.57 | 1.63 | 2.46 | 2.29 | 1.99 | 2.73 | 3.62 | 3.47 |
| Debt / assetsi | 10.31 | 24.86 | 24.46 | 21.06 | 23.33 | 20.65 | 20.33 | 16.88 |
| LT debt / equityi | 42.37 | 103.37 | 96.80 | 77.84 | 79.73 | 75.21 | 80.86 | 63.88 |
| Interest coveragei | 1.97 | 2.64 | 11.78 | 23.79 | 2.91 | 1.68 | 2.20 | 3.44 |
| Revenue CAGR (3Y) %i | 2.19 | 6.40 | 9.21 | 13.31 | 2.44 | 1.38 | 0.91 | 13.82 |
| Net income CAGR (3Y) %i | 145.11 | -- | 75.34 | 76.54 | -15.15 | -37.39 | -23.36 | 66.16 |
| FCF CAGR (3Y) %i | -- | -- | -- | 11.23 | -11.33 | -- | -- | 56.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.10 | 10.25 | 9.64 | 16.18 | 10.65 | 10.94 |
| ROA %i | 2.23 | 2.52 | 2.36 | 4.18 | 2.63 | 2.60 |
| ROIC %i | 8.43 | 8.79 | 8.93 | 13.27 | 8.84 | 8.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.72 | 14.46 | 13.63 | 18.18 | 13.21 | 12.87 |
| FCF / sales %i | -- | 1.89 | 5.14 | 11.21 | 5.07 | -- |
| Current ratioi | 4.12 | 5.25 | 5.21 | 5.99 | 5.20 | 4.58 |
| Quick ratioi | 3.90 | 3.09 | 3.03 | 3.47 | 3.08 | 2.69 |
| Debt / assetsi | 24.97 | 25.10 | 18.92 | 16.88 | 20.12 | 21.08 |
| LT debt / equityi | 102.25 | 103.20 | 78.51 | 63.88 | 80.59 | 90.67 |
| Interest coveragei | 2.23 | 2.41 | 2.39 | 3.44 | 2.70 | 2.85 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Wealth Management is the largest reported line at 59.94% of revenue, across 3 reported segments.
- Capital Markets follows at 39.39%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Wealth Management59.94%
Capital Markets39.39%
Corporate/other0.67%
Quote time 2026-10-08 04:01:04 · For reference only, not investment advice and not tailored to your situation.